PJSC Pharmaceutical Plant Egis (quality control, secondary packaging)

The drug is prescribed for the treatment of breast cancer (metastatic or early stage) and metastatic gastric or gastroesophageal junction cancer, provided the patient has HER2 protein overexpression.

Dosage form: lyophilisate for concentrate for infusion solution

ATC: L01FD01